Below are the most recent publications written about "Neuroblastoma" by people in Profiles.
-
Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS, Dent MH, Fortina P, Reynolds CP, Maris JM. Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci Data. 2017 03 28; 4:170033.
-
Bresler SC, Weiser DA, Huwe PJ, Park JH, Krytska K, Ryles H, Laudenslager M, Rappaport EF, Wood AC, McGrady PW, Hogarty MD, London WB, Radhakrishnan R, Lemmon MA, Mossé YP. ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma. Cancer Cell. 2014 Nov 10; 26(5):682-94.
-
Eloy JA, Mady LJ, Kanumuri VV, Svider PF, Liu JK. Modified subtotal-Lothrop procedure for extended frontal sinus and anterior skull-base access: a case series. Int Forum Allergy Rhinol. 2014 Jun; 4(6):517-21.
-
Sethi D, Chen CP, Jing RY, Thakur ML, Wickstrom E. Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells. Bioconjug Chem. 2012 Feb 15; 23(2):158-63.
-
Eloy JA, Friedel ME, Eloy JD, Mirani NM, Liu JK. Bilateral olfactory fossa respiratory epithelial adenomatoid hamartomas. Arch Otolaryngol Head Neck Surg. 2011 Aug; 137(8):820-2.
-
Gutierrez JC, Cheung MC, Zhuge Y, Koniaris LG, Sola JE. Does Children's Oncology Group hospital membership improve survival for patients with neuroblastoma or Wilms tumor? Pediatr Blood Cancer. 2010 Oct; 55(4):621-8.
-
Vitali R, Mancini C, Cesi V, Tanno B, Piscitelli M, Mancuso M, Sesti F, Pasquali E, Calabretta B, Dominici C, RaschellĂ G. Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model. Int J Cancer. 2009 Dec 1; 125(11):2547-55.
-
Muthumani K, Lambert VM, Shanmugam M, Thieu KP, Choo AY, Chung JC, Satishchandran A, Kim JJ, Weiner DB, Ugen KE. Anti-tumor activity mediated by protein and peptide transduction of HIV viral protein R (Vpr). Cancer Biol Ther. 2009 Jan; 8(2):180-7.
-
Gutierrez JC, Koniaris LG, Cheung MC, Byrne MM, Fischer AC, Sola JE. Cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery. Surgery. 2009 Jan; 145(1):76-85.
-
Adekar SP, Takahashi T, Jones RM, Al-Saleem FH, Ancharski DM, Root MJ, Kapadnis BP, Simpson LL, Dessain SK. Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain. PLoS One. 2008; 3(8):e3023.